Breccia M, Iurlo A, Pane F, Scortechini AR, Rossi AR, Santoro M, Cerrano M, Lunghi F, Maggi A, Di Renzo N, Sargentini V, Piciocchi A, Tringali C, Malato A. Long-term safety and efficacy of ponatinib in intolerant chronic myeloid leukemia: subanalysis of the observational study of Iclusig® (ponatinib) treatment in patients with chronic myeloid leukemia in Italy. Haematologica; https://doi.org/10.3324/haematol.2026.300586 [Early view].